New data revealed that nearly 100 percent (99%) of 200 U.S. primary care physicians surveyed agree that heart disease and stroke are the number one cause of death and disability among type 2 diabetes patients; however, almost 40 percent (36%) of these physicians underestimate the number of patients who die from cardiovascular disease. Furthermore, while people with diabetes are two to four times more likely to have heart disease than people without diabetes, the survey, conducted by Harris Interactive and supported by Merck, found only one out of five (21%) patients (n=664) listed heart attack or heart failure as their biggest worry regarding diabetes complications, and even fewer patients (7%) listed stroke.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/merck/50638/
OneTouch®, a leading brand of blood glucose monitoring systems for people with diabetes, has introduced Life First™, a new North American campaign featuring music legend B.B. King and Crystal Bowersox, one of music’s most talented new artists. The ads debut on national and regional television today and will be followed by online and print ads over the next several months. The introduction of the campaign is particularly timely, since March 22 marks National Diabetes Alert Day in the U.S.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/onetouch/48943/
In support of American Diabetes Month®, Colgate Total® is working with the American Diabetes Association to educate patients about diabetes and gum disease and to empower them to help take charge of their diabetes.
A recent survey conducted by Harris Interactive on behalf of Colgate Total® about oral health reveals a lack of awareness about the various health issues associated with diabetes. More than one third of all respondents (36%) are not aware of the link between diabetes and oral health and are less likely to associate oral health issues with diabetes than almost all other health conditions related to diabetes. More than half (54%) report one or more symptoms of gum disease – yet 67% do not discuss their oral health with their doctor.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58614-colgate-total-american-diabetes-association-oral-health-and-diabetes
Golden Globe and Emmy nominated actress Elizabeth Perkins, who is living with type 1 diabetes, is partnering with Sanofi US on the Diabetes Co-Stars awareness campaign to produce a new documentary that will feature people living with diabetes and those who support them. Beginning today through December 16, 2012, people can submit their stories to the nationwide casting call at www.DiabetesCoStars.com.
To view Multimedia News Release, go to https://www.multivu.com/mnr/57457-sanofi-us-elizabeth-perkins-casting-call-diabetes-co-stars-documentary
New findings from an oral health study conducted earlier this year by United Concordia Dental and Highmark Inc. show pharmacy costs can average $1,477 lower per year for diabetics who have gum disease and receive at least seven treatments or visits to treat the disease.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58161-highmark-united-concordia-dental-gum-disease-pharmacy-costs-diabetes
Interim clinical results from Project IMPACT: Diabetes, announced today by the American Pharmacists Association (APhA) Foundation, show statistically significant decreases in A1C or blood sugar levels, LDL cholesterol, systolic blood pressure and Body Mass Index (BMI), which are all recognized standards of diabetes care. Participating patients in 25 communities who experienced improved outcomes encompass almost every socioeconomic class, insurance status and ethnicity.
To view Multimedia News Release, go to http://www.multivu.com/mnr/62268-american-pharmacists-association-apha-foundation-project-impact-diabetes
Nearly 26 million Americans have diabetes, which can affect numerous parts of the body, including your teeth and gums.
Of the 26 million people who have diabetes, an estimated 7 million have no idea that they have the disease, according to the American Diabetes Association. With those figures in mind, the American Dental Association (ADA) recommends that regular health care checkups may help to identify potential signs of diabetes.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/60005-american-dental-association-diabetes-recommendations
Diabetic Foot Ulcers (DFUs) are one of the most common, yet treatable, complications in people with diabetes. As part of World Diabetes Day, Shire is today urging diabetes patients to have their feet checked and visit www.healtogether.com to better understand the complications associated with diabetes.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64401-shire-urges-people-with-diabetes-feet-for-wounds-world-diabetes-day
The first comprehensive long-term study comparing different medications for type 2 diabetes is launching nationwide. The GRADE (Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness) Study will compare the long-term benefits and risks of four widely used diabetes drugs in combination with metformin, the most common first-line medication for treating type 2 diabetes.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64578-grade-glycemia-reduction-approaches-in-diabetes-comparative-effectiveness
Se pone en marcha el primer estudio integral a largo plazo que compara diferentes medicaciones para el tratamiento de la diabetes tipo 2 a escala nacional. El estudio GRADE (Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness - Estrategias para la reducción de la glucemia en la diabetes: una comparativa de la eficacia) comparará los efectos beneficiosos y riesgos a largo plazo de cuatro fármacos ampliamente utilizados en el tratamiento de la diabetes, en combinación con metformina, la medicación de primera línea más frecuente para tratar la diabetes tipo 2. El estudio GRADE está buscando voluntarios latinos.
Para ver el Multimedia News Release, vaya a http://www.multivu.com/mnr/65066-nih-grade-study-on-type-2-diabetes-medication-seeks-latino-volunteers
Novo Nordisk today announces the launch of ‘Cities Changing Diabetes’, an ambitious new partnership programme to fight the urban diabetes challenge. The ‘Cities Changing Diabetes’ programme will first be launched in Mexico City with other cities in North America, Europe and Asia soon to follow.
“The global diabetes epidemic is an emergency in slow motion,
